6.
Chen H, Lee C, Chang C, Ni Y, Shyu M, Chen S
. Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. Hepatology. 2015; 62(2):375-86.
DOI: 10.1002/hep.27837.
View
7.
DUNCAN G, Christian H
. An evaluation of immune serum globulin as a prophylactic agent against homologous serum hepatitis. Am J Med Sci. 2010; 213(1):53-7.
DOI: 10.1097/00000441-194701000-00008.
View
8.
Sarin S, Kumar M, Eslam M, George J, Al Mahtab M, Akbar S
. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019; 5(2):167-228.
PMC: 7164809.
DOI: 10.1016/S2468-1253(19)30342-5.
View
9.
Funk A, Lu Y, Yoshida K, Zhao T, Boucheron P, Holten J
. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2020; 21(1):70-84.
DOI: 10.1016/S1473-3099(20)30586-7.
View
10.
Pan C, Duan Z, Dai E, Zhang S, Han G, Wang Y
. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. N Engl J Med. 2016; 374(24):2324-34.
DOI: 10.1056/NEJMoa1508660.
View
11.
. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017; 67(2):370-398.
DOI: 10.1016/j.jhep.2017.03.021.
View
12.
Blumberg B, Alter H, VISNICH S
. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965; 191:541-6.
DOI: 10.1001/jama.1965.03080070025007.
View
13.
Latthaphasavang V, Vanhems P, Ngo-Giang-Huong N, Sibounlang P, Paboriboune P, Malato L
. Perinatal hepatitis B virus transmission in Lao PDR: A prospective cohort study. PLoS One. 2019; 14(4):e0215011.
PMC: 6481786.
DOI: 10.1371/journal.pone.0215011.
View
14.
Pattyn J, Hendrickx G, Vorsters A, Van Damme P
. Hepatitis B Vaccines. J Infect Dis. 2021; 224(12 Suppl 2):S343-S351.
PMC: 8482019.
DOI: 10.1093/infdis/jiaa668.
View
15.
Weng M, Doshani M, Khan M, Frey S, Ault K, Moore K
. Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(13):477-483.
PMC: 8979596.
DOI: 10.15585/mmwr.mm7113a1.
View
16.
Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C
. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B. N Engl J Med. 2018; 378(10):911-923.
PMC: 5895092.
DOI: 10.1056/NEJMoa1708131.
View
17.
Chen H, Lin L, Hu F, Lee J, Lin W, Yang Y
. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2011; 142(4):773-781.e2.
DOI: 10.1053/j.gastro.2011.12.035.
View
18.
Yang T, Vargas-Zambrano J, Park H, Jung C, Kim D, Jee Y
. Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus. Hum Vaccin Immunother. 2023; 19(3):2278940.
PMC: 10653619.
DOI: 10.1080/21645515.2023.2278940.
View
19.
Stevens C, Toy P, Kamili S, Taylor P, Tong M, Xia G
. Eradicating hepatitis B virus: The critical role of preventing perinatal transmission. Biologicals. 2017; 50:3-19.
DOI: 10.1016/j.biologicals.2017.08.008.
View
20.
Smalls D, Kiger R, Norris L, Bennett C, Love B
. Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy. 2019; 39(12):1190-1203.
PMC: 6893091.
DOI: 10.1002/phar.2340.
View